4//SEC Filing
Hopman Mark 4
Accession 0001415889-25-023743
CIK 0001674632other
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 6:45 PM ET
Size
5.2 KB
Accession
0001415889-25-023743
Insider Transaction Report
Form 4
Hopman Mark
Chief Commercial Officer
Transactions
- Sale
Common Stock
2025-09-02$18.86/sh−848$15,996→ 33,284 total
Footnotes (2)
- [F1]The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.
- [F2]The weighted average sale price for the transaction reported was $18.8632 and the range of prices were between $18.58 and $19.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Documents
Issuer
Beta Bionics, Inc.
CIK 0001674632
Entity typeother
Related Parties
1- filerCIK 0002048497
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 6:45 PM ET
- Size
- 5.2 KB